Skip to main content
. 2021 Nov 8;21:1144. doi: 10.1186/s12879-021-06821-1

Table 26.

Immunomodulatory therapies used among those who used antibiotic therapy

Total (n = 13,932) No. (%) With antibiotics n = 12,238 (%) Without antibiotics n = 1498 (%) p value
Use of lopinavir/ritonavir 13,719 8414 (61.3) 7590 (62.1) 824 (55.0) < 0.001
Use of hydroxychloroquine 13,727 11,727 (85.4) 10,677 (87.3) 1050 (70.1) < 0.001
Use of beta-Interferon 13,662 1585 (11.6) 1488 (12.2) 97 (6.5) < 0.001
Use of tocilizumab 13,703 1145 (8.4) 1106 (9.1) 39 (2.6) < 0.001
Use of anakinra 13,604 76 (0.6) 76 (0.6) 0 (0) < 0.001
Use of systemic corticosteroids 13,689 4738 (34.6) 4500 (36.9) 238 (16.0) < 0.001
Use of immunoglobulin 13,483 62 (0.5) 60 (0.5) 2 (0.1) 0.06